EUVIMEDEUVIMED entdecken
Crossref

Tandem Cyclization–Ring Opening of Chromenylamidines: A Direct Route to Pyrido[2,3‍‐‍ d ]pyrimidin‐4(1 H )‐Ones With Anticancer Activity

Fábio P Lima iD, Mónica Cerqueira iD, Ana Silva, Beatriz Sousa, Mariana G Coelho iD, Julieta Afonso iD, Fátima Baltazar iD, Marta Costa, Fernanda Proença iD

ChemMedChem · 12.11.2026 · 21 (21)

DOI: 10.1002/cmdc.70540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 03.11.2026. Verfasst von Fábio P Lima und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Minho, Braga, Portugal. Hauptthemen laut MEDLINE: Antineoplastic Agents, Pyrimidinones, Benzopyrans. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyrido[2,3‐ d ]pyrimidinones can be considered privileged heterocyclic scaffolds as they are present in a diversity of molecules with a wide range of biological activities. This work describes a novel synthesis of pyrido[2,3‐ d ]pyrimidin‐4(1 H )‐ones from chromenylamidines by a cascade cyclization–ring‐opening reaction, induced by acetic acid catalysis and heating in ethanol. Preliminary biological evaluation identified several derivatives with significant and selective cytotoxic activity for triple‐negative breast cancer cell lines (low micromolar EC 50 values). This methodology provides a straightforward approach to 1,5,7‐triarylpyridopyrimidinones from readily available 4 H ‐chromene precursors, enabling access to a library of compounds with promising cytotoxic activity in cancer cell models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsPyrimidinonesBenzopyransCyclizationHumansDrug Screening Assays, AntitumorStructure-Activity RelationshipCell Line, TumorCell ProliferationMolecular Structure

Stichwörter der Autor:innen

4H‐chromenesanticancercromenylamidinespyrido[2,3‐d]pyrimidin‐4(1H)‐onestandem cyclization–ring‐opening reactions

Substanzen

Antineoplastic AgentsPyrimidinonesBenzopyrans

Autor:innen und Institutionen

  • Department of Chemistry, University of Minho, Braga, Portugal.
  • Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
  • ICVS/3Bs-PT Government Associate Laboratory, Guimarães, Portugal.

ORCID-Profile: Fábio P Lima, Mónica Cerqueira, Mariana G Coelho, Julieta Afonso, Fátima Baltazar, Fernanda Proença

Förderung

  • Fundação para a Ciência e a Tecnologia

Zitieren

APA

Lima, F. P., Cerqueira, M., Silva, A., Sousa, B., Coelho, M. G., Afonso, J., Baltazar, F., Costa, M., & Proença, F. (2026). Tandem Cyclization–Ring Opening of Chromenylamidines: A Direct Route to Pyrido[2,3‍‐‍ d ]pyrimidin‐4(1 H )‐Ones With Anticancer Activity. ChemMedChem, 21(21). https://doi.org/10.1002/cmdc.70540

Vancouver

Lima FP, Cerqueira M, Silva A, Sousa B, Coelho MG, Afonso J, et al. Tandem Cyclization–Ring Opening of Chromenylamidines: A Direct Route to Pyrido[2,3‍‐‍ d ]pyrimidin‐4(1 H )‐Ones With Anticancer Activity. ChemMedChem. 2026;21(21). doi:10.1002/cmdc.70540

BibTeX
@article{Lima2026,
  author = {Lima, Fábio P and Cerqueira, Mónica and Silva, Ana and Sousa, Beatriz and Coelho, Mariana G and Afonso, Julieta and Baltazar, Fátima and Costa, Marta and Proença, Fernanda},
  title = {Tandem Cyclization–Ring Opening of Chromenylamidines: A Direct Route to Pyrido[2,3‍‐‍ d ]pyrimidin‐4(1 H )‐Ones With Anticancer Activity},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {21},
  doi = {10.1002/cmdc.70540}
}
Kostenlos starten →